APYX
Apyx Medical Inc
2.90$
-4.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 67.5% | 57.5% | 51.1% | 49.2% | 35.3% | 32.4% | 36.8% | 30.7% | 34.6% | 35.5% | 39.0% | 64.0% | |
| 32.5% | 42.5% | 48.9% | 50.8% | 64.7% | 67.6% | 63.2% | 69.3% | 65.4% | 64.5% | 61.0% | 36.0% | |
| 5.1% | 7.3% | 7.1% | 6.3% | 14.8% | 13.2% | 14.1% | 8.9% | 10.2% | 9.3% | 10.6% | 6.4% | |
| 48.5% | 58.9% | 52.1% | 54.1% | 127.0% | 128.3% | 121.5% | 90.1% | 108.2% | 93.3% | 89.7% | 68.3% | |
| 53.6% | 66.2% | 59.3% | 60.4% | 141.7% | 141.5% | 135.6% | 99.0% | 118.4% | 97.5% | 100.2% | 48.2% | |
| -21.1% | -23.7% | -10.4% | -13.5% | -81.5% | -73.9% | -72.5% | -29.8% | -52.9% | -33.0% | -39.2% | -12.2% | |
| 0.5% | 0.5% | 0.4% | 0.3% | 0.6% | 0.0% | 0.2% | 0.0% | 0.0% | 4.7% | 12.3% | 10.6% | |
| -48.0% | -18.1% | -10.6% | -13.4% | -79.5% | -70.3% | -70.0% | -30.5% | -51.5% | -40.7% | -48.5% | -20.5% | |
| 14.4% | 0.1% | 0.2% | -0.4% | -22.6% | -0.5% | -27.1% | 0.8% | 0.8% | -4.6% | 0.5% | 0.5% | |
| -62.4% | -18.2% | -10.8% | -13.0% | 383.6% | -69.8% | -42.9% | -31.3% | -52.1% | -35.7% | -48.8% | -21.2% | |
| -18.0% | -20.9% | -8.3% | -33.4% | -83.4% | -67.6% | -66.7% | -28.7% | -49.4% | -34.6% | -34.9% | -8.7% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.